These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7903382)

  • 1. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
    Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
    Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
    Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
    J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
    Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
    Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
    Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
    Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
    Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity.
    Bartholdy C; Nansen A; Marker O; Thomsen AR
    Clin Exp Immunol; 1999 May; 116(2):299-306. PubMed ID: 10337022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
    Infection; 1996; 24(4):301-8. PubMed ID: 8875282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
    Joyce DA; Steer JH
    Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of beta2-microglobulin, neopterin, TNF-alpha and soluble receptors of TNF-alpha and interleukin-2 in intravenous drug abusers according to HIV-1 status and stage of the HIV-1 infection.
    Bedini JL; García F; Miró JM; Aznar E; Serrano J; Lozano L; Mallolas J; Filella X; Vidal J; Latorre X; Gatell JM; Ballesta AM; Soriano E
    Clin Microbiol Infect; 1998 Jan; 4(1):4-10. PubMed ID: 11864226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients.
    Bilello JA; Stellrecht K; Drusano GL; Stein DS
    J Infect Dis; 1996 Feb; 173(2):464-7. PubMed ID: 8568313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
    Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
    Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of body mass index with urinary neopterin in individuals infected with human immunodeficiency virus.
    Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
    Int Arch Allergy Immunol; 1994; 104(2):150-4. PubMed ID: 7911045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
    Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes.
    Rimaniol AC; Boussin F; Herbelin A; De Groote D; Dormont D; Bach JF; Descamps-Latscha B; Zavala F
    Eur J Immunol; 1994 Sep; 24(9):2055-60. PubMed ID: 8088326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss.
    Denz H; Orth B; Weiss G; Gallati H; Herrmann R; Huber P; Wachter H; Fuchs D
    Eur J Cancer; 1993; 29A(16):2232-5. PubMed ID: 8110491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.
    Zangerle R; Fuchs D; Reibnegger G; Werner-Felmayer G; Gallati H; Wachter H; Werner ER
    Immunobiology; 1995 Jun; 193(1):59-70. PubMed ID: 7590863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble intercellular adhesion molecule-1, soluble E-selectin, tumor necrosis factor-alpha, and soluble tumor necrosis factor receptor p55 and p75 in atopic children.
    Laan MP; Koning H; Baert MR; Oranje AP; Buurman WA; Savelkoul HF; Neijens HJ
    Allergy; 1998 Jan; 53(1):51-8. PubMed ID: 9491229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Abe S; Inoue S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1179-84. PubMed ID: 10764309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.